Aspirin/Caffeine/Codeine Phosphate/Butalbital

阿司匹林/咖啡因/磷酸可待因/布他比妥

Report date: 2022/07/05 20:38:36

Base Information

Drug NameAspirin/Caffeine/Codeine Phosphate/Butalbital
Drug Alias NameAspirin/Caffeine/Butalbital/Codeine phosphateFioricet with Codeine
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsGamma-aminobutyric acid A receptor agonistsAdenosine A1 receptor antagonists +[5] 
TargetsOpioid receptorsGamma-aminobutyric acid A receptorAdenosine A1 receptor +[5] 
Therapy Area/IndicationsHeadache
Global Approved IndicationsHeadache
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/10/26
Country/TerritoryUnited States
CombinationsYes ButalbitalCaffeineAspirin
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsHeadache

Other Information

ATC CodeN02AA59
Related LinksN/A